Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kees Hendricksen

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Urology|December 11, 2017
Lymphatic Drainage from Renal Tumors In Vivo: A Prospective Sentinel Node Study Using SPECT/CT ImagingTeele Kuusk, Roderick De Bruijn, Oscar R Brouwer, et al.
The Journal of Urology|January 4, 2020
Efficacy of Preoperative Chemotherapy for High Risk Upper Tract Urothelial CarcinomaBeat Foerster, Mohammad Abufaraj, Firas Petros, et al.
European Urology Focus|October 28, 2017
Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European SurveyKees Hendricksen, Atiqullah Aziz, Perrine Bes, et al.
World Journal of Urology|September 3, 2025
Routine annual imaging does not aid in diagnosing new functional complications more than five years after RC with ileal conduitJoanneke B Ringia, Femke E F Scholte, Renee A G Lijnen, et al.
BJU International|June 24, 2025
Evaluating follow-up in patients with lymph node-negative penile cancer at a high-volume centreManon T A Vreeburg, Gerben M Vaessen, Hielke M de Vries, et al.
Journal of Surgical Oncology|May 1, 2023
Age represents the main driver of surgical decision making in patients candidate to radical cystectomyPaolo Dell'Oglio, Stefano Tappero, Andrea Panunzio, et al.
Cancers|December 11, 2022
Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial GroupGautier Marcq, Luca Afferi, Yann Neuzillet, et al.
European Urology Open Science|August 2, 2021
Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer GroupTom-Régis Dobé, Gianluigi Califano, Friedrich-Carl von Rundstedt, et al.
World Journal of Urology|May 13, 2026
Multi-institutional external validation of the European risk classification for high-grade Ta non-muscle-invasive bladder cancerManon Cournède, Pierre-Etienne Gabriel, Marine Lottin, et al.
World Journal of Urology|January 12, 2026
Second-look transurethral resection in high-grade Ta non-muscle invasive bladder cancerSophie Régnier, Pierre-Etienne Gabriel, Idir Ouzaid, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Urology|December 11, 2017
Lymphatic Drainage from Renal Tumors In Vivo: A Prospective Sentinel Node Study Using SPECT/CT ImagingTeele Kuusk, Roderick De Bruijn, Oscar R Brouwer, et al.
The Journal of Urology|January 4, 2020
Efficacy of Preoperative Chemotherapy for High Risk Upper Tract Urothelial CarcinomaBeat Foerster, Mohammad Abufaraj, Firas Petros, et al.
European Urology Focus|October 28, 2017
Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European SurveyKees Hendricksen, Atiqullah Aziz, Perrine Bes, et al.
World Journal of Urology|September 3, 2025
Routine annual imaging does not aid in diagnosing new functional complications more than five years after RC with ileal conduitJoanneke B Ringia, Femke E F Scholte, Renee A G Lijnen, et al.
BJU International|June 24, 2025
Evaluating follow-up in patients with lymph node-negative penile cancer at a high-volume centreManon T A Vreeburg, Gerben M Vaessen, Hielke M de Vries, et al.
Journal of Surgical Oncology|May 1, 2023
Age represents the main driver of surgical decision making in patients candidate to radical cystectomyPaolo Dell'Oglio, Stefano Tappero, Andrea Panunzio, et al.
Cancers|December 11, 2022
Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial GroupGautier Marcq, Luca Afferi, Yann Neuzillet, et al.
European Urology Open Science|August 2, 2021
Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer GroupTom-Régis Dobé, Gianluigi Califano, Friedrich-Carl von Rundstedt, et al.
World Journal of Urology|May 13, 2026
Multi-institutional external validation of the European risk classification for high-grade Ta non-muscle-invasive bladder cancerManon Cournède, Pierre-Etienne Gabriel, Marine Lottin, et al.
World Journal of Urology|January 12, 2026
Second-look transurethral resection in high-grade Ta non-muscle invasive bladder cancerSophie Régnier, Pierre-Etienne Gabriel, Idir Ouzaid, et al.
Pageof 10